Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Aligos Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 68
- +10 vs. Q2 2021
- Shares held
- 31.2M
- +4.19M (+15.5%) vs. Q2 2021
- Total value
- $483.9M
- −$66.6M (−12.1%) vs. Q2 2021
- New holders
- 16
- 30 more added
- Sold out
- 6
- 10 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State of Wyoming | 91 | $1.00K | 0.00% | −44−32.6% | Reduced |
| Newbridge Financial Services Group, Inc. | 37 | $1.00K | 0.00% | 00.0% | Unchanged |
| Evolution Wealth Advisors, LLC | 194 | $3.00K | 0.00% | −123−38.8% | Reduced |
| US Bancorp | 413 | $6.00K | 0.00% | +394+2,073.7% | Added |
| UBS Group AG | 728 | $11.0K | 0.00% | +377+107.4% | Added |
| Tower Research Capital LLC (TRC) | 873 | $14.0K | 0.00% | −593−40.5% | Reduced |
| Point72 Hong Kong Ltd | 1,357 | $21.0K | 0.00% | +1,357 | New |
| Ameritas Investment Partners, Inc. | 1,471 | $23.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,768 | $27.0K | 0.00% | +484+37.7% | Added |
| Citigroup Inc | 3,122 | $48.0K | 0.00% | +1,037+49.7% | Added |
| O'Shaughnessy Asset Management, LLC | 3,261 | $51.0K | 0.00% | +3,261 | New |
| Advisor Group Holdings, Inc. | 4,500 | $70.0K | 0.00% | +4,500 | New |
| Macquarie Group Ltd | 5,786 | $90.0K | 0.00% | +5,786 | New |
| Hershey Trust Co | 6,063 | $94.0K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 6,507 | $100.9K | 0.00% | +146+2.3% | Added |
| Virtus ETF Advisers LLC | 6,814 | $106.0K | 0.05% | −353−4.9% | Reduced |
| Legal & General Group Plc | 7,822 | $121.0K | 0.00% | +5,175+195.5% | Added |
| MetLife Investment Management | 8,308 | $128.9K | 0.00% | 00.0% | Unchanged |
| SG Americas Securities, LLC | 8,383 | $130.0K | 0.00% | +8,383 | New |
| American International Group, Inc. | 11,558 | $179.0K | 0.00% | +1,045+9.9% | Added |
| Manufacturers Life Insurance Company, The | 12,276 | $190.0K | 0.00% | +1,192+10.8% | Added |
| Rhumbline Advisers | 13,599 | $211.0K | 0.00% | +1,059+8.4% | Added |
| Credit Suisse AG | 13,624 | $211.0K | 0.00% | +13,624 | New |
| Golden State Wealth Management, LLC | 14,860 | $230.0K | 0.05% | 00.0% | Unchanged |
| ETF Managers Group, LLC | 15,558 | $236.0K | 0.00% | +4,304+38.2% | Added |
| JPMorgan Chase & Co | 15,684 | $244.0K | 0.00% | −10,225−39.5% | Reduced |
| Algert Global LLC | 16,146 | $250.0K | 0.03% | +16,146 | New |
| Jump Financial, LLC | 16,100 | $250.0K | 0.02% | +16,100 | New |
| New York State Common Retirement Fund | 16,300 | $253.0K | 0.00% | +102+0.6% | Added |
| Two Sigma Advisers, LP | 16,500 | $256.0K | 0.00% | +16,500 | New |
| Sectoral Asset Management Inc | 16,908 | $262.0K | 0.02% | 00.0% | Unchanged |
| HarbourVest Partners LLC | 18,783 | $291.0K | 0.03% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 23,737 | $368.0K | 0.00% | −14,231−37.5% | Reduced |
| State of Wisconsin Investment Board | 24,300 | $377.0K | 0.00% | +3,575+17.2% | Added |
| Price T Rowe Associates Inc | 27,279 | $423.0K | 0.00% | +49+0.2% | Added |
| California State Teachers Retirement System | 32,126 | $498.0K | 0.00% | +6,236+24.1% | Added |
| Altium Capital Management LP | 33,492 | $519.0K | 0.14% | +33,492 | New |
| Bank of America Corp | 33,729 | $522.0K | 0.00% | +16,985+101.4% | Added |
| Bank of New York Mellon Corp | 48,501 | $752.0K | 0.00% | +3,080+6.8% | Added |
| Renaissance Technologies LLC | 53,200 | $825.0K | 0.00% | +53,200 | New |
| Swiss National Bank | 56,200 | $872.0K | 0.00% | +22,600+67.3% | Added |
| Millennium Management LLC | 69,943 | $1.08M | 0.00% | +69,943 | New |
| Deutsche Bank AG | 83,752 | $1.30M | 0.00% | −12,739−13.2% | Reduced |
| Nuveen Asset Management, LLC | 88,224 | $1.37M | 0.00% | +24,008+37.4% | Added |
| Two Sigma Investments, LP | 89,863 | $1.39M | 0.00% | +89,863 | New |
| Point72 Asset Management, L.P. | 97,300 | $1.51M | 0.01% | +97,300 | New |
| Norges Bank | 102,400 | $1.59M | 0.00% | +102,400 | New |
| Sofinnova Investments, Inc. | 124,342 | $1.93M | 0.12% | −39,709−24.2% | Reduced |
| Charles Schwab Investment Management Inc | 135,330 | $2.10M | 0.00% | +46,291+52.0% | Added |
| Northern Trust Corp | 198,311 | $3.08M | 0.00% | +20,297+11.4% | Added |
| Sphera Funds Management Ltd. | 249,197 | $3.87M | 0.38% | +249,197 | New |
| Geode Capital Management, LLC | 313,655 | $4.86M | 0.00% | +58,307+22.8% | Added |
| State Street Corp | 374,232 | $5.80M | 0.00% | +75,645+25.3% | Added |
| Morgan Stanley | 469,404 | $7.28M | 0.00% | +453,545+2,859.9% | Added |
| Cormorant Asset Management, LP | 667,167 | $10.3M | 0.42% | −238,300−26.3% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $13.6M | 4.80% | 00.0% | Unchanged |
| BlackRock Inc. | 1,239,562 | $19.2M | 0.00% | +155,518+14.3% | Added |
| Vanguard Group Inc | 1,275,215 | $19.8M | 0.00% | +291,919+29.7% | Added |
| Federated Hermes, Inc. | 1,475,000 | $22.9M | 0.04% | +975,000+195.0% | Added |
| Boxer Capital, LLC | 1,526,048 | $23.7M | 0.83% | 00.0% | Unchanged |
| Logos Global Management LP | 1,962,785 | $30.4M | 2.20% | +1,750,000+822.4% | Added |
| Baker Bros. Advisors LP | 2,076,400 | $32.2M | 0.14% | +466,400+29.0% | Added |
| Versant Venture Management, LLC | 2,320,381 | $36.0M | 14.90% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 2,365,064 | $36.7M | 0.48% | +200,000+9.2% | Added |
| Janus Henderson Group PLC | 2,440,476 | $37.7M | 0.02% | +180,709+8.0% | Added |
| Novo Holdings A/S | 2,614,563 | $40.6M | 2.10% | 00.0% | Unchanged |
| Vivo Capital, LLC | 3,547,030 | $55.0M | 2.47% | 00.0% | Unchanged |
| Wellington Management Group LLP | 3,829,383 | $59.4M | 0.01% | −346,198−8.3% | Reduced |
| VR Adviser, LLC | 0 | $0 | 0.00% | −408,377−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −214,254−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −24,889−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −16,355−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −15,237−100.0% | Sold out |
| Hamilton Lane Advisors LLC | 0 | $0 | 0.00% | −12,127−100.0% | Sold out |